Feasibility and Safety of a Combined Augmented Reality and Functional Electrical Stimulation System

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity Health Network, Toronto

About this trial

Cervical spinal cord injury (cSCI) can result in substantial loss of upper-limb function, with associated socio-economic impact on affected individuals and the healthcare system. Evidence suggests that non-invasive neuromodulation such as functional electrical stimulation (FES) therapy can contribute to regaining upper-limb function, which is a top priority for this population. This pilot study will involve individuals with cSCI using a device that combines augmented reality (AR) and functional electrical stimulation (FES) for 20, one-hour sessions over a 10-week period. The sessions will include upper-limb rehabilitation where individuals will interact with different objects with the aid of the AR +FES system. The primary objective is to assess safety and feasibility, measured by the absence of serious adverse events and participants' ability to independently set up and use the system. Secondary objectives include adherence to the intervention and user feedback through structured interviews. Exploratory outcomes will examine preliminary efficacy using clinical measures such as the Spinal Cord Independence Measure (SCIM) and the Graded Redefined Assessment of Strength, Sensation and Prehension (GRASSP).

Eligibility criteria

Qualifiers

Chronic cervical SCI

Any level or severity of cervical SCI, traumatic or non-traumatic

Can carry out object manipulations but with visible impairment (i.e., 5-25 on the GRASSP Prehension Performance sub-score).

Disqualifiers

Any disease or injury other than the SCI that may be affecting grasping performance.

Individuals with any self-reported FES contraindications (pacemakers, implantable defibrillator, implanted neurostimulation device, metallic implants in the stimulated areas, cardiac conditions, epilepsy, uncontrolled seizures, wounds or fractures on the target limb)

Inability to understand the study procedures

Muscles do not respond to FES to produce grasping movements

Trial design

Treatments tested in this trial

  • AR + FES

Treatment groups

7 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor

Canadian Training Platform for Trials Leveraging Existing Networks

Collaborator